【Portfolio News】Portfolio ONI closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital
GT Healthcare Capital Partners is excited about the closing of a $75M series B round of ONI, a pioneer in super resolution imaging for single molecules in living cells with offices in San Diego, CA (HQ) and Oxford, UK.
The round was led by ARCH Venture Partners and Casdin Capital, with participation from Section 32, ARTIS Ventures, Vertical Venture Partners, Axon Ventures and private investors, including Paul Conley. Existing investors, including Oxford Science Enterprises, and GT Healthcare Capital Partners also participated in the round.
Proceeds from the financing will be used to grow ONI’s commercial and R&D teams in the US and Asia, driving technology adoption in those geographies. Funds will also be used to expand ONI’s portfolio of consumables and cloud-based software apps.
ONI’s first product, the Nanoimager, is the world’s first desktop, super-resolution, single-molecule imaging platform capable of visualizing and tracking individual molecules in complex systems such as nanoparticles, living cells and tissue with 20nm resolution. ONI was founded in 2016 as a spin-out of Oxford University. For more information, visit oni.bio and follow ONI on Twitter @oniHQ and LinkedIn @ONI.